Clinical Trials Directory

Trials / Completed

CompletedNCT01112371

Contractubex Treatment in Scars After Abdominal Caesarean Section

A Prospective, Single-center, Randomized, Parallel Group Trial to Investigate the Efficacy of Contractubex® Gel, Containing Extractum Cepae, Allantoin, and Heparin, in Scars After Abdominal Caesarean Section

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
61 (actual)
Sponsor
Merz Pharmaceuticals GmbH · Industry
Sex
Female
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the efficacy of Contractubex® Gel, containing extractum cepae, allantoin and heparin, in the treatment of scars after abdominal Caesarean section compared to untreated scars after abdominal Caesarean section.

Conditions

Interventions

TypeNameDescription
DRUGContractubexContractubex® Gel, containing 10% extractum cepae, 1% allantoin and 50/U of sodium heparin per one gram of gel. Active drug group: The gel will be applied twice daily (morning/evening). Approximately 2 cm of the IMP are applied onto the scar by light massage rubbing carefully until the product is worked in.

Timeline

Start date
2011-02-01
Primary completion
2012-02-01
Completion
2012-02-01
First posted
2010-04-28
Last updated
2014-04-08

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT01112371. Inclusion in this directory is not an endorsement.